Literature DB >> 24662142

AIDS and disseminated tuberculosis after Immune Reconstitution Inflammatory Syndrome.

Gonul Sengoz1, Ahmet Sengoz2, Filiz Pehlivanoglu3.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24662142      PMCID: PMC9427471          DOI: 10.1016/j.bjid.2014.01.004

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


× No keyword cloud information.
A 29-year-old male patient was admitted at the hospital with complaints of diarrhea and weight loss that had started two months ago. In his physical examination and laboratory tests, HIV positivity was detected (CD4 cell count 175 mL–1, HIV RNA 9,800,000 copies/mL). At the end of the first month of antiretroviral therapy he was admitted to the hospital again with deterioration in his general medical condition, respiratory distress and loss of consciousness. Massive pleural effusion in the right hemithorax, and diffuse bilateral micronodular infiltration in both lungs were detected by thoracic computerized tomographic (CT) examination (Fig. 1). A lesion (tuberculoma) was observed in the cranial magnetic resonance imaging (MRI) (Fig. 2). There were hypodense nodular lesions in the liver and spleen, and mesenchymal multiple lymphadenopathy (LAP) in the abdominal CT (Fig. 3). Mycobacterium tuberculosis grew on the 35th day after pleural fluid culture in Löwenstein Jensen culture media. Treatment with antituberculosis agents and 60 mg prednisolone was started. Bilateral distal motor and sensory neuropathy developed during follow-up. Multiple nodular lesions (tuberculomas) were detected in the spine in spinal MRI (Fig. 4). The patient was discharged on the second month of treatment with partial recovery.
Fig. 1

Massive pleural effusion in the right hemithorax, diffuse bilateral micronodular infiltration in both lungs, and hilar lymphadenopathy in thoracic CT.

Fig. 2

Lesion on the right cerebellar hemisphere of approximately 1 cm, which was hypointense in T1 and hyperintense in T2 weighted images in cranial MRI.

Fig. 3

Hypodense nodular lesions in the liver and spleen, and mesenchymal multiple lymphadenopathy in the abdominal CT.

Fig. 4

Multiple nodular lesions (tuberculomas) in the vertebral corpus in spinal MRI.

Massive pleural effusion in the right hemithorax, diffuse bilateral micronodular infiltration in both lungs, and hilar lymphadenopathy in thoracic CT. Lesion on the right cerebellar hemisphere of approximately 1 cm, which was hypointense in T1 and hyperintense in T2 weighted images in cranial MRI. Hypodense nodular lesions in the liver and spleen, and mesenchymal multiple lymphadenopathy in the abdominal CT. Multiple nodular lesions (tuberculomas) in the vertebral corpus in spinal MRI. Initiation of antiretroviral therapy (ART) in HIV-infected patients leads to restoration of the immune functions. On the other hand, dysregulated immune response after initiation of ART leads to the phenomenon of Immune Reconstitution Inflammatory Syndrome (IRIS). IRIS is paradoxical worsening of an existing infection or appearance of a new infection soon after initiation of ART.2, 3

Conflicts of interest

The authors declare no conflicts of interest.
  3 in total

1.  Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.

Authors:  G Breton; A Bourgarit; S Pavy; D Bonnet; V Martinez; X Duval; P Longuet; S Abgrall; A Simon; C Leport
Journal:  Int J Tuberc Lung Dis       Date:  2012-10       Impact factor: 2.373

2.  Tuberculosis-Associated Immune Reconstruction Inflammatory Syndrome (TB-IRIS) in HIV-Infected Patients: Report of Two Cases and the Literature Overview.

Authors:  Klaudija Viskovic; Josip Begovac
Journal:  Case Rep Infect Dis       Date:  2013-04-18

3.  Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome.

Authors:  Maryline Bonnet; Elisabeth Baudin; Ilesh V Jani; Elizabete Nunes; François Verhoustraten; Alexandra Calmy; Rui Bastos; Nilesh B Bhatt; Christophe Michon
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.